Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer

Apatinib, an anti-tumor drug selectively targeting VEGFR2 (Vascular Endothelia Growth Factor Recpetor-2), has been proven effective in Chinese patients with liver cancer. Generally, treatment with apatinib achieves 16.1% of the overall objective remission rate (ORR) and 55.83% of the disease control...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Hui, Zhou, Cheng, Luo, Zhaoxia, Zhang, Ping, Zhu, Liping, Gong, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107464/
https://www.ncbi.nlm.nih.gov/pubmed/33981598
http://dx.doi.org/10.3389/fonc.2021.624369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107464/
https://www.ncbi.nlm.nih.gov/pubmed/33981598
http://dx.doi.org/10.3389/fonc.2021.624369

Ejemplares similares